Abstract
The efficacy and safety of thalidomide as an initial treatment in myeloma patients who were unsuitable for autologous stem cell transplantation (ASCT), as induction treatment prior to ASCT, or as a maintenance treatment was unclear. The purpose of this study was to assess the benefits and risks of thalidomide for previously untreated myeloma patients. MEDLINE, EMBASE, and Cochrane Library were searched for randomized controlled trials (RCTs) of thalidomide used in either induction or maintenance therapy for previously untreated myeloma patients. Twenty-two RCTs enrolling 9098 patients were identified, including 15 RCTs of induction thalidomide, 6 RCTs of maintenance thalidomide, and 1 RCT of induction and maintenance thalidomide. Induction thalidomide improved overall response rate (ORR) (risk ratio (RR) 1.54, 95 % confidence interval (CI) 1.30-1.83), complete response rate (CRR) (RR 3.03, 95 % CI 1.91-4.80), progression-free survival (PFS) (hazard ratio (HR) 0.65, 95 % CI 0.56-0.76), and overall survival (OS) (HR 0.78, 95 % CI 0.67-0.91) in patients who were not allowed to receive ASCT. Induction thalidomide improved pre-ASCT ORR (RR 1.20, 95 % CI 1.11-1.30), pre-ASCT and post-ASCT CRR (RR 1.47, 95 % CI 1.12-1.93 and RR 1.23, ...Continue Reading
References
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Feb 20, 2004·Leukemia·R García-SanzJ F San Miguel
Oct 8, 2004·Leukemia·M C MinnemaH M Lokhorst
Dec 21, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Vincent RajkumarUNKNOWN Eastern Cooperative Oncology Group
Mar 15, 2006·Lancet·Antonio PalumboUNKNOWN Italian Multiple Myeloma Network, GIMEMA
Jul 29, 2006·Blood·Michel AttalUNKNOWN Inter-Groupe Francophone du Myélome (IFM)
Jun 9, 2007·Trials·Jayne F TierneyMatthew R Sydes
Aug 19, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K ZervasUNKNOWN Greek Myeloma Study Group
Sep 19, 2007·Blood·Abderrahman AbdelkefiUNKNOWN Tunisian Multiple Myeloma Study Group
Oct 9, 2007·Lancet·Thierry FaconUNKNOWN Intergroupe Francophone du Myélome
Mar 26, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Vincent RajkumarJoan Bladé
Apr 3, 2008·Cancer Treatment Reviews·Lisa K HicksUNKNOWN Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-based Care
May 22, 2008·Blood·Bart BarlogieJohn Crowley
Oct 29, 2008·Blood·Heinz LudwigAxel Hinke
Mar 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew SpencerNola Kennedy
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cyrille HulinPhilippe Moreau
Jun 13, 2009·Blood·Abderrahman AbdelkefiMohamed Hsaïri
Nov 3, 2009·Blood·Henk M LokhorstUNKNOWN Dutch-Belgian Hemato-Oncology Group (HOVON)
Apr 27, 2010·Haematologica·Heinz LudwigNiklas Zojer
May 8, 2010·Blood·Anders WaageUNKNOWN Nordic Myeloma Study Group
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pierre WijermansUNKNOWN Dutch-Belgium Cooperative Group HOVON
Oct 15, 2010·European Journal of Haematology·Meral BeksacLevent Undar
Jun 10, 2011·Blood·Gareth J MorganUNKNOWN NCRI Haematological Oncology Study Group
Aug 19, 2011·Blood·Philippe MoreauJean-Luc Harousseau
Oct 25, 2011·Blood·Gareth J MorganUNKNOWN National Cancer Research Institute Haematological Oncology Clinical Studies Group
Nov 8, 2011·Haematologica·Gareth J MorganUNKNOWN National Cancer Research Institute Haematological Oncology Clinical Studies Group
Jun 26, 2012·American Journal of Hematology·Angelo MaiolinoUNKNOWN Brazilian Multiple Myeloma Study Group (BMMSG/GEMOH)
Jan 9, 2013·Blood·A Keith StewartRalph M Meyer
Jan 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio PalumboMichele Cavo
Sep 12, 2014·Computational and Structural Biotechnology Journal·Ivan Spicka
Citations
Dec 3, 2016·Journal of Psychopharmacology·Jeffrey A Lieberman, Daniel Shalev
Jan 31, 2019·Expert Review of Hematology·Iuliana Vaxman, Morie Gertz
Apr 14, 2017·Oncotarget·De-Dong CaoWei Ge
Sep 21, 2017·Oncology Letters·Clemens B TempferGünther A Rezniczek
Jun 4, 2021·Frontiers in Genetics·Yi HeHao Cheng